Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 283

Similar articles for PubMed (Select 15912393)

1.

Uptake of angiotensin II receptor blockers in the treatment of hypertension.

Greving JP, Denig P, van der Veen WJ, Beltman FW, Sturkenboom MC, de Zeeuw D, Haaijer-Ruskamp FM.

Eur J Clin Pharmacol. 2005 Jul;61(5-6):461-6. Epub 2005 May 24.

PMID:
15912393
2.

Does comorbidity explain trends in prescribing of newer antihypertensive agents?

Greving JP, Denig P, van der Veen WJ, Beltman FW, Sturkenboom MC, de Zeeuw D, Haaijer-Ruskamp FM.

J Hypertens. 2004 Nov;22(11):2209-15.

PMID:
15480107
3.

Patterns of persistence with antihypertensive medications in newly diagnosed hypertensive patients in Italy: a retrospective cohort study in primary care.

Mazzaglia G, Mantovani LG, Sturkenboom MC, Filippi A, Trifirò G, Cricelli C, Brignoli O, Caputi AP.

J Hypertens. 2005 Nov;23(11):2093-100.

PMID:
16208153
4.

Initial treatment of hypertension and adherence to therapy in general practice in Italy.

Poluzzi E, Strahinja P, Vargiu A, Chiabrando G, Silvani MC, Motola D, Sangiorgi Cellini G, Vaccheri A, De Ponti F, Montanaro N.

Eur J Clin Pharmacol. 2005 Sep;61(8):603-9. Epub 2005 Aug 5.

PMID:
16082539
5.

Use of ACE inhibitors and ARBs in hypertensive women of childbearing age.

Martin U, Foreman MA, Travis JC, Casson D, Coleman JJ.

J Clin Pharm Ther. 2008 Oct;33(5):507-11. doi: 10.1111/j.1365-2710.2008.00938.x.

PMID:
18834365
6.

Discontinuation of and changes in drug therapy for hypertension among newly-treated patients: a population-based study in Italy.

Corrao G, Zambon A, Parodi A, Poluzzi E, Baldi I, Merlino L, Cesana G, Mancia G.

J Hypertens. 2008 Apr;26(4):819-24. doi: 10.1097/HJH.0b013e3282f4edd7.

PMID:
18327094
7.

Prevalence and management of hypertension in primary care in Portugal. Insights from the VALSIM study.

Cortez-Dias N, Martins S, Belo A, Fiuza M; Investigadores do Estudo VALSIM.

Rev Port Cardiol. 2009 May;28(5):499-523. English, Portuguese.

8.

Antihypertensive drug prescription trends at the primary health care centres in Bahrain.

Jassim al Khaja KA, Sequeira RP, Wahab AW, Mathur VS.

Pharmacoepidemiol Drug Saf. 2001 May;10(3):219-27.

PMID:
11501335
9.

Determinants for the adoption of angiotensin II receptor blockers by general practitioners.

Greving JP, Denig P, van der Veen WJ, Beltman FW, Sturkenboom MC, Haaijer-Ruskamp FM.

Soc Sci Med. 2006 Dec;63(11):2890-8. Epub 2006 Sep 7.

PMID:
16959390
10.

Patterns of antihypertensive therapy in new users of angiotensin II-receptor blockers.

Young CH, Zhang K, Poret AW.

Am J Health Syst Pharm. 2005 Nov 15;62(22):2381-5.

PMID:
16278329
11.

Temporal trends in antihypertensive drug prescriptions in Canada before and after introduction of the Canadian Hypertension Education Program.

Campbell NR, McAlister FA, Brant R, Levine M, Drouin D, Feldman R, Herman R, Zarnke K; Canadian Hypertension Education Process and Evaluation Committee.

J Hypertens. 2003 Aug;21(8):1591-7.

PMID:
12872055
12.

Hypertension guidelines in elderly patients: is anybody listening?

Tu K, Mamdani MM, Tu JV.

Am J Med. 2002 Jul;113(1):52-8.

PMID:
12116987
13.

Persistence with antihypertensive treatments: results of a 3-year follow-up cohort study.

Hasford J, Schröder-Bernhardi D, Rottenkolber M, Kostev K, Dietlein G.

Eur J Clin Pharmacol. 2007 Nov;63(11):1055-61. Epub 2007 Aug 14.

PMID:
17701032
14.

Changing patterns of initial drug therapy for the treatment of hypertension in a Medicaid population, 2001-2005.

Weiss R, Buckley K, Clifford T.

J Clin Hypertens (Greenwich). 2006 Oct;8(10):706-12.

PMID:
17028484
15.
16.

Relation of the first hypertension-associated event with medication, compliance and persistence in naïve hypertensive patients after initiating monotherapy.

Mathes J, Kostev K, Gabriel A, Pirk O, Schmieder RE.

Int J Clin Pharmacol Ther. 2010 Mar;48(3):173-83.

PMID:
20197011
17.

Discontinuation of antihypertensive drugs among newly diagnosed hypertensive patients in UK general practice.

Burke TA, Sturkenboom MC, Lu SE, Wentworth CE, Lin Y, Rhoads GG.

J Hypertens. 2006 Jun;24(6):1193-200.

PMID:
16685222
18.

[Current status of antihypertensive drug treatment in primary care practice at launch of the new renin inhibitor aliskiren (RASANT)].

Müller A, Schweizer J, Kirch W, Schindler C; RASANT-Studiengruppe.

Med Klin (Munich). 2010 Mar;105(3):155-62. doi: 10.1007/s00063-010-1025-7. Epub 2010 Mar 28. German.

PMID:
20349293
19.

Underuse of ACE inhibitors and angiotensin II receptor blockers in elderly patients with diabetes.

Winkelmayer WC, Fischer MA, Schneeweiss S, Wang PS, Levin R, Avorn J.

Am J Kidney Dis. 2005 Dec;46(6):1080-7.

PMID:
16310574
20.

Usefulness of the alpha1-blocker doxazosin as a third-line antihypertensive drug.

Ohta Y, Tsuchihashi T, Onaka U, Eto K, Ueno M.

Hypertens Res. 2007 Apr;30(4):301-6.

PMID:
17541208
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk